Literature DB >> 19182427

Polymyositis with atypical pathological features associated with thymic carcinoma.

Yumiko Azuma1, Kensuke Shiga, Ryotaro Ishii, Tatsuyuki Yamaguchi, Fumitoshi Niwa, Masanori Nakagawa.   

Abstract

A 66-year-old man was admitted for progressive proximal weakness and myalgia in his shoulder girdles without skin lesions. A muscle biopsy showed infiltration of inflammatory cells, degeneration of muscle fibers, and perifascicular atrophy. Remarkably, MHC-I antigen was expressed in the muscle membrane and most of the inflammatory cells were CD8-positive, suggesting that class-I antigen-dependent cytotoxic T-cells played a crucial role in the muscle pathology, which supported a diagnosis of polymyositis rather than dermatomyositis. Magnetic resonance imaging of his chest revealed two mediastinal tumors, which were extirpated and diagnosed as thymic carcinoma. The muscle weakness was completely recovered after the operation and subsequent administration of oral prednisolone. Postoperative clinical improvement and decline of serum creatinine kinase suggested a paraneoplastic nature of the polymyositis in this patient.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19182427     DOI: 10.2169/internalmedicine.48.1136

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  3 in total

Review 1.  Management of thymic tumors: a European perspective.

Authors:  Enrico Ruffini; Federico Venuta
Journal:  J Thorac Dis       Date:  2014-05       Impact factor: 2.895

2.  An interesting collection of paraneoplastic syndromes in a patient with a malignant thymoma.

Authors:  Emaddin S Kidher; Natalia Briceno; Ali Taghi; Andrew Chukwuemeka
Journal:  BMJ Case Rep       Date:  2012-07-03

3.  Paraneoplastic dermatomyositis as presentation of thymic carcinoma.

Authors:  Andrea Dell'Amore; Nizar Asadi; Guido Caroli; Giampiero Dolci; Alessandro Bini; Franco Stella
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-08-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.